VitMode

Migraine and Magnesium: Does Supplementation Really Prevent Attacks?

Magnesium for migraine gets recommended almost reflexively, somewhere between grandma's advice and "just in case" supplementation — but this time there's more behind the recommendation than tradition. A fresh 2025 dose-response meta-analysis, covering 22 randomized trials, shows that magnesium supplementation reduced migraine attack frequency by an average of 2.51 episodes per month versus placebo, while also reducing pain severity and the number of migraine days per month. That result is comparable to, and in some respects better than, other well-known preventive interventions like CoQ10 or vitamin D. In this article, we look closely at what these numbers show, how they stack up against other supplements tested in the same study, and why this is a different topic from our article on magnesium and sleep quality — despite sharing the same mineral, the mechanism and clinical context are entirely separate.

PZdr Piotr ZielińskiAugust 24, 202612 min read
Table of contents

Why magnesium is considered for migraine in the first place

Magnesium serves functions in the body that are important for proper nervous system function — it's involved in regulating nerve signaling, blood vessel function, and inflammatory processes. Hypotheses about magnesium's role in migraine trace back to observations that some migraine patients had lower intracellular magnesium concentrations than people without migraine, prompting researchers to test supplementation as a potential preventive intervention.

For years, this topic mostly lived in the realm of recommendations based on single, smaller studies and clinical tradition, without a solid, pooled analysis covering many studies at once. That changed only with the newest dose-response meta-analysis.

This is a separate topic from magnesium and sleep

Our entry on magnesium glycinate vs. citrate for sleep concerns a completely different application — sleep quality, not migraine prevention. Despite sharing the same mineral, the mechanisms of action, dosing, and clinical contexts differ enough that it's worth treating these two topics separately.

What the 2025 dose-response meta-analysis shows

The work by Talandashti and colleagues, published in 2025 in Neurological Sciences, is a systematic review and dose-response meta-analysis assessing several selected dietary supplements for migraine prophylaxis, including magnesium.

Effects of selected dietary supplements on migraine prophylaxis: a systematic review and dose-response meta-analysis

Moderate evidence

Talandashti MK, Shahinfar H, Delgarm P, Jazayeri S · Neurological Sciences · 2025

The meta-analysis covered 22 randomized trials assessing the effect of magnesium supplementation on migraine prophylaxis compared to placebo. Magnesium supplementation reduced migraine attack frequency (mean difference MD=-2.51), severity (MD=-0.88), and monthly migraine days (MD=-1.66) compared to the control group. For comparison, the same work also assessed other supplements: CoQ10 (MD=-1.73 for attack frequency), riboflavin (MD=-1.34), vitamin D (MD=-1.69), probiotics (MD=-1.16); omega-3 fatty acids showed no significant effect.

View study

Magnesium performs best among the assessed supplements for attack frequency

Moderate evidence

In direct comparison with other supplements assessed in the same meta-analysis, magnesium showed the greatest reduction in migraine attack frequency (MD=-2.51) among all tested interventions, outperforming vitamin D, CoQ10, riboflavin, and probiotics. This is important context — this isn't a single, isolated study, but a result embedded in a direct comparison with competing preventive options.

What "mean difference" means and why this distinction matters

It's worth precisely understanding what the -2.51 figure represents. This is a mean difference (MD) obtained by pooling results from 22 heterogeneous clinical trials — not the result of one large, groundbreaking RCT. This means individual component studies differed in methodology, magnesium doses, chemical forms of the compound, and patient populations, and the meta-analysis averages these differences to produce a pooled picture of the effect.

Myth

Magnesium for migraine is purely folk wisdom without solid scientific backing.

Fact

The 2025 dose-response meta-analysis, covering 22 randomized trials, shows a statistically measurable effect of magnesium on migraine attack frequency, severity, and monthly migraine days — comparable to or better than other tested preventive interventions. This doesn't prove magnesium works for every migraine patient, but it moves the topic from the anecdote level to the level of measurable, pooled scientific evidence.

This heterogeneity of component studies is simultaneously a strength and a weakness of the meta-analysis — on one hand, it shows the effect holds despite methodological differences between studies; on the other, it makes it harder to precisely determine the optimal dose or form of magnesium based on this single work.

What this means in practice

Practical takeaways from the Talandashti et al. meta-analysis

  • Magnesium showed the greatest reduction in migraine attack frequency (-2.51/month) among the supplements assessed in this meta-analysis
  • The effect covers three different dimensions: attack frequency, pain severity, and monthly migraine days — not just one parameter
  • This is a pooled result from 22 heterogeneous studies, not one precisely standardized RCT — magnesium doses and forms differed between component studies
  • Omega-3 fatty acids showed no significant effect in the same meta-analysis — not every "health-promoting" supplement works in the context of migraine
  • Decisions about magnesium supplementation for migraine prevention are worth discussing with a neurologist, especially for chronic migraine or frequent, severe attacks

In practice, this means someone dealing with recurring migraine who's looking for a low-risk preventive option has, in magnesium, an intervention with more solid scientific support than many other commonly recommended supplements in this context.

Limitations worth keeping in mind

What this meta-analysis doesn't prove

The key limitation is exactly the heterogeneity of component studies — the 22 trials differed in magnesium doses, chemical forms (different magnesium salts have different bioavailability), intervention duration, and patient characteristics (e.g. episodic vs. chronic migraine). The meta-analysis provides an averaged, pooled picture of the effect, but doesn't unambiguously specify the optimal dose or form of magnesium to use for migraine prevention. This is also a mean difference from studies with varying risk of systematic bias, not the result of one large, high-quality RCT — it's worth treating this as a solid, but pooled, signal, not final, precise dosing guidelines.

Practical summary

QuestionShort answer
Does magnesium reduce migraine attack frequency?Yes, according to a 22-RCT meta-analysis — an average of 2.51 fewer attacks/month vs. placebo
How does it compare to other supplements?Best in terms of attack frequency among the options assessed (CoQ10, riboflavin, vitamin D, probiotics)
Is this one large study?No — this is a pooled meta-analysis of 22 heterogeneous studies, not a single RCT
Does this also apply to sleep quality?No — this is a separate topic from our article on magnesium and sleep
How strong is the evidence?Moderate — a consistent signal in pooled data, but limited by study heterogeneity

Migraine and magnesium in brief

Our editorial recommendation

Migraine is a topic where patients often test supplements through trial and error, without a solid reference point. This meta-analysis provides exactly that reference point — magnesium performs better here than several other equally popular options, though still in the form of a pooled, averaged result, not an unambiguous, precise dosing recommendation.

If you're dealing with recurring migraine and considering supplementation as part of prevention, magnesium is an option with more solid scientific support than many other commonly recommended supplements — though it's worth discussing dose and form with a neurologist, especially if your migraine is chronic or attacks are frequent and severe.

It's rare for something as simple as magnesium to outperform more sophisticated supplement options in direct comparison — but that's exactly what this meta-analysis shows.

Dr. Piotr Zieliński, VitMode editorial team

Frequently asked questions

The Talandashti et al. meta-analysis doesn't specify a single optimal dose due to the heterogeneity of the 22 component studies, which differed in magnesium doses and forms. A specific dose is worth establishing individually with a neurologist.

The meta-analysis didn't assess time to effect onset, only the pooled reduction in attack frequency, pain severity, and migraine days after a supplementation period. In terms of reducing attack frequency, magnesium performed best among the options assessed.

No — these are separate applications with different mechanisms and clinical contexts. Our entry on magnesium glycinate vs. citrate for sleep concerns sleep quality, not migraine prevention, even though it's the same element.

No — the studies included in the meta-analysis assessed magnesium as part of prevention, not a substitute for treating acute attacks or preventive pharmacotherapy prescribed by a doctor. Decisions about combining supplementation with treatment should always be discussed with a neurologist.

Sources

PZ

dr Piotr Zieliński

Specialist physician in endocrinology, scientific consultant

Piotr reviews content on hormones, metabolic health and supplement pharmacology.

Related articles

Zbliżenie białych kapsułek wysypujących się z pojemnika na fioletowym tle

Magnesium Glycinate or Citrate for Sleep: What Does the Evidence Actually Say?

Search "magnesium for sleep" and you'll immediately land on a confident recommendation: glycinate, never citrate, because it "absorbs better" and "doesn't cause a laxative effect." The problem is that no study in healthy people with poor sleep has ever compared these two forms head-to-head — not for sleep quality, not for absorption. What looks like settled supplement wisdom is actually an evidence gap that marketing has filled with its own narrative.

11 min

August 23, 2026

Trzy brązowe butelki z tabletkami magnezu na jasnoróżowym tle

Which Magnesium Should You Choose? Glycinate, Citrate or Lactate — Comparing the Forms

The supplement shelf can be overwhelming: glycinate, citrate, lactate, oxide, chelate... We compare the most popular forms of magnesium for absorption, price, and what each one is actually best suited for.

10 min

August 18, 2026

Osoba wrzucająca tabletkę musującą do szklanki z wodą

Zinc and the Common Cold: Does It Really Shorten It?

"Zinc shortens colds" is one of the oldest claims in supplementation — and one of the few backed by meta-analyses with concrete numbers. But this story has an instructive plot twist: part of the key Cochrane evidence was withdrawn over data errors. We break down the topic, including what you shouldn't trust uncritically.

11 min

August 22, 2026

Portret mężczyzny w średnim wieku z profilu, widoczna cofająca się linia włosów

Creatine and Hair Loss: Does the Supplement Really Raise DHT?

"Creatine causes baldness" is one of the most repeated warnings in gym culture — and it rests on exactly one study from 2009, which never measured hair loss at all. That study did show a real spike in DHT, the hormone responsible for pattern hair loss, up 56% after a week of creatine loading. The catch: nobody since has ever tested whether that DHT spike actually translates into real hair loss — and those are very different questions.

11 min

August 23, 2026

Related knowledge base entries

Comments (2)

  • KW

    Kasia W. 2 weeks ago

    Very clearly explained, especially the interactions section — I hadn't seen it laid out this well anywhere else.

  • MT

    Marek T. a month ago

    Are you planning to update this with the newest study from this year? I saw an interesting meta-analysis.